SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
Stock Information for SciSparc Ltd.
Loading
Please wait while we load your information from QuoteMedia.